Company intelligence / Profile preview

Yourgene Health

Manchester, England, United Kingdomyourgenehealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Yourgene Health has commercialized several molecular diagnostic products, including the CE-marked IONA test for non-invasive prenatal testing and other assays such as cystic fibrosis screening and DPYD genotyping. The company’s tests are used globally in over 65 countries, with IVDR certification achieved for key products. No clinical trial results typical of therapeutics; instead, regulatory approvals and accreditations demonstrate performance.[3][4][5]

Therapeutic areas: OncologyRare DiseasesWomen's Health
Modalities: Diagnostic assayDevice
Industry: Molecular Diagnostics

Partnerships

GenetixPacBio Compatible Partner program

Beyond the preview

Go deeper on Yourgene Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yourgene Health.

Explore the full profile